Prognostic and Diagnostic Glycan-Based Biomarkers of Brain Damage
The present disclosure relates to glycan-based biomarkers for the diagnosis or prognosis of brain damage, such as traumatic brain injury (TBI).
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English |
Published |
26.11.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure relates to glycan-based biomarkers for the diagnosis or prognosis of brain damage, such as traumatic brain injury (TBI). |
---|---|
Bibliography: | Application Number: US202016913394 |